Skip to main content
Mark Sklar, MD, Endocrinology, Washington, DC

Mark Mendel Sklar MD

Endocrinology•Washington, DC

Diabetes, Lipid Metabolism, Thyroid

Mark Sklar, M.D.

Join to View Full Profile

  • 3 Washington Cir NWSte 303Washington, DC 20037

  • Phone+1 202-887-4769

  • Fax+1 202-223-2552

Dr. Sklar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Sklar's Full ProfileAlready have an account?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1984 - 1987
  • Mount Sinai Hospital
    Mount Sinai Hospital1984 - 1985
  • Boston University
    Boston UniversityB.A, Summa Cum Laude, 1984 - 1984
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1984

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1985 - Present
  • DC State Medical License
    DC State Medical License 1990 - 2026
  • VA State Medical License
    VA State Medical License 1990 - 2026
  • MD State Medical License
    MD State Medical License 1987 - 2006
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification Practice Fusion, Practice Fusion, 2011, 2013, 2017
  • CMS Meaningful Use Stage 2 Certification Practice Fusion EHR, Practice Fusion, 2011, 2013, 2017
  • CMS Meaningful Use Stage 2 Certification Practice Fusion EHR, Practice Fusion, 2011, 2013, 2017

Publications & Presentations

PubMed

Journal Articles

  • A Doctor’s Reflections on Health-Care Reform.  
    Sklar, Mark, The Wall Street Journal
  • The Very-Low Fat, High-Fiber Diet in the Treatment of NIDDM: A Randomized, Controlled, Intervention Study.  
    Nicholson AS, Sklar MM, Gore S, Sullivan R, Browning S, Journal of Preventive Medicine
  • Oral Hypoglycemics for NIDDM: Singly, Combined and With Insulin.  
    Khodor M, and Sklar, MM, Consultant; 35:361-372

Books/Book Chapters

  • Insulin-Like Growth Factors: Molecular and Cellular Aspects. 
    Chapter: The Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor 
    Page 111 - 150Nissley P, Kiess W, and Sklar MEditors: LeRoith D.CRC Press, Boca Raton

Abstracts/Posters

  • Increased IGF-II Receptor Gene Expression and Binding During Liver Regeneration.
    Burguera B, Werner H, Sklar M, Roberts CT, LeRoith D, The American Diabetes Association Meetings
  • The Rat Insulin-Like Growth Factor-II (IGF-II)/Mannose-6-Phosphate (M6P) Receptor mRNA Is Developmentally Regulated in Multiple Tissues.
    Sklar MM, Thomas CL, Municchi G, Kress W, Nissley SP, Endocrine Society
  • Evidence that Beta-Galactosidase Inhibits Insulin-Like Growth Factor-II (IGF-II) Binding to the IGF-II/Mannose-6-Phosphate Recognition Site.
    Kiess W, Sklar MM, Thomas C, Nissley SP, Endocrine Society

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Mark Sklar, Dr. Mark Sklar, MD, Dr. M Sklar, Dr. Mark Mendel Sklar